Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Files Patent Infringement Suit Against Shimadzu

NEW YORK (GenomeWeb News) – Caliper Life Sciences has filed a suit against Shimadzu claiming that the Japanese firm's microfluidic system infringes 11 patents held by Caliper.

The suit, which was filed last week in the US District Court for the Eastern District of Texas, alleges that Shimadzu's MCE-202 MultiNA instrument system, a microchip-based electrophoresis system that performs DNA and RNA size confirmation and quantitation, infringes its patents. The Shimadzu instrument uses the microchip technology to conduct fully automated, high-speed electrophoresis separation and uses fluorescence detection to perform high-sensitivity analysis, Caliper said in its suit.

Caliper sells LabChip systems that also conduct electrophoretic DNA separation and IVIS molecular imaging systems using fluorescence and bioluminescence.

Caliper has asked the court to declare that Shimadzu and its American subsidiary, Shimadzu Scientific Instruments, are infringing Caliper's patents. It also has asked the court to enter a permanent injunction barring Shimadzu from selling its microfluidic system, and it has asked for the court to award it triple damages due to alleged willful infringement.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.